Medicare clozapine data analysis.

<div><p>Schizophrenia-spectrum disorders are debilitating and contribute to a substantial economic burden. Clinicians have historically underutilized clozapine, an atypical antipsychotic traditionally reserved for treatment-resistant schizophrenia, due to the medication’s adverse effect...

Celý popis

Uloženo v:

Podrobná bibliografie
Hlavní autor:	Luke R. Cavanah (19022435) (author)
Další autoři:	Maria Y. Tian (22075705) (author), Jessica L. Goldhirsh (16229023) (author), Leighton Y. Huey (19022438) (author), Brian J. Piper (9870935) (author)
Vydáno:	2025
Témata:	Genetics Immunology Cancer Mental Health Environmental Sciences not elsewhere classified underutilization &# 8212 substantial economic burden spending (&# 8722 reduced suicide ideation medication &# 8217 cause mortality benefits associated management requirements adverse effect profile xlink "> schizophrenia pronounced geographic heterogeneity alleviating schizophrenia symptoms historically underutilized clozapine characterize clozapine utilization us medicaid recipients population (&# 8722 poor treatment adherence patterns previously identified 2015 &# 8722 corrected clozapine use clozapine use adjusted pronounced state variation us medicare patients pronounced state medicare patients clozapine use resistant schizophrenia level variation substance use training reform steady decrease spectrum disorders south dakota prescribed significantly practical solutions inadequate training education interventions demonstrated effectiveness 9 %)
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Medicare clozapine data analysis.

Podobné jednotky